Latest Sales Growth News

NuEnergy Gas Limited has announced a $4.62 million entitlement offer, primarily to fund early gas sales and development of its Indonesian coal bed methane assets. The offer is partially underwritten by a major shareholder and supports key milestones in the company’s transition to commercial production.

Tinybeans Group Ltd has announced its strategic acquisition of US-based family journaling platform Qeepsake, nearly doubling its paid subscriber base and accelerating its path to profitability through product integration and expanded revenue streams.

Oldfields Holdings navigated a challenging first quarter of FY2026 with tight cash flow and subdued sales but made strategic moves to streamline operations and bolster scaffold order backlogs for growth.

KNeoMedia reports significant progress toward ASX reinstatement, driven by strategic capital raises and the expansion of its KneoScience platform into New York high schools, boosting potential revenue and student reach.

Freehill Mining shifts focus to cement industry feedstocks, stabilizes operations after plant challenges, and secures fresh capital while reporting promising magnetite test results.

Metgasco’s latest quarterly report reveals a 24% drop in sales revenue amid ongoing Production Uplift Program activities, while reserves remain stable and strategic farm-out talks advance.

Cobram Estate Olives Limited has reported a record-breaking FY2025, driven by strong sales growth in Australia and the USA, alongside a $178 million equity raise to accelerate its Californian olive grove expansion.

Australian Bond Exchange Holdings (ASX – ABE) unveiled new AUD-denominated market-linked securities and progressed its AI-driven credit analysis tool, while reporting a $0.7 million quarterly cash outflow and plans for capital raising.

Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Hydralyte USA reported a 6% year-on-year sales increase in Q3 FY25 alongside a significant 42% reduction in operating cash burn, driven by a streamlined US-focused model and new product launches in brain and gut health.